Recce Pharmaceuticals Doses All Patients in Phase II Trial of RECCE® 327 Topical Gel in Acute Bacterial Skin and Skin Structure Infections
Preliminary data indicates patients experienced either a complete cure or significant improvement in infection symptoms ...